Biomolecules, 2022, 12(2):189

Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications

The purpose of our review is to briefly show what different compounds of marine origin, from low molecular weight ones to peptides and proteins, offer for understanding the structure and mechanism of action of nicotinic acetylcholine receptors (nAChRs) and for finding novel drugs to combat the diseases where nAChRs may be involved. The importance of the mentioned classes of ligands has changed with time; a protein from the marine snake venom was the first excellent tool to characterize the muscle-type nAChRs from the electric ray, while at present, muscle and α7 receptors are labeled with the radioactive or fluorescent derivatives prepared from α-bungarotoxin isolated from the many-banded krait. The most sophisticated instruments to distinguish muscle from neuronal nAChRs, and especially distinct subtypes within the latter, are α-conotoxins. Such information is crucial for fundamental studies on the nAChR revealing the properties of their orthosteric and allosteric binding sites and mechanisms of the channel opening and closure. Similar data are provided by low-molecular weight compounds of marine origin, but here the main purpose is drug design. In our review we tried to show what has been obtained in the last decade when the listed classes of compounds were used in the nAChR research, applying computer modeling, synthetic analogues and receptor mutants, X-ray and electron-microscopy analyses of complexes with the nAChRs, and their models which are acetylcholine-binding proteins and heterologously-expressed ligand-binding domains.

IBCH: 9852
Ссылка на статью в журнале: https://www.mdpi.com/2218-273X/12/2/189
Кол-во цитирований на 04.2024: 10
Данные статьи проверены модераторами 2022-02-01

Список научных проектов, где отмечена публикация

  1. 17-00-00064. . Сommercial.
  2. 17-00-00052. . Сommercial.
  3. -Роль гетеромерных никотиновых ацетилхолиновых рецепторов макрофагов в регуляции воспалительных процессов и иммуносупрессии. (January 6, 2022 — December 31, 2023). Tsetlin V.I.. Grant, RSF.
  4. The study of the Cys-loop receptor's role in neuroimmune interactions of glioblastoma multiforme (July 1, 2021 — June 30, 2024). Kudryavtsev D.S., Antipova N.V., Ivanov I.A., Shelukhina I.V.. Grant, RSF, 18000000 rub..
  5. - (January 6, 2020 — December 31, 2022). Andreev Y.A.. Grant, RFBR.